<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04185571</url>
  </required_header>
  <id_info>
    <org_study_id>THE2010-01</org_study_id>
    <nct_id>NCT04185571</nct_id>
  </id_info>
  <brief_title>Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis</brief_title>
  <acronym>NutriPEPA2</acronym>
  <official_title>Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theradial</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theradial</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      NutriPEPA2 is a randomized, single-blind, prospective, multicenter trial, in two parallel
      arms to confirm that the adsorbent PEPA membrane may decrease mortality related to
      inflammation and malnutrition encountered in HD or HDF-treated stage 5 renal failure compared
      to a non-adsorbent synthetic membrane.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of NutriPEPA2 study is to demonstrate that the use of an adsorbent membrane
      (PEPA-Poly Ester Poly Arylate synthetic co-polymer membrane) decreases undernutrition (often
      associated with inflammation) and consequently morbidity, comparing one year mortality in
      patients with Chronic Kidney Disease (CKD), with severe Protein-Energy Wasting (PEW), treated
      with dialysis using a non-adsorbent synthetic membrane (Polysulfone or Polyethersulfone)
      versus an adsorbent membrane (PEPA).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 12, 2011</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, single-blind, prospective, multicenter trial, in two parallel arms</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients will be randomized and included in one of the following 2 groups group 1: PEPA membrane / group 2: non-adsorbent synthetic membrane . The randomization will be stratified on the center</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Possible decrease mortality in patients arm treated with PEPA membrane</measure>
    <time_frame>one year</time_frame>
    <description>Superiority of mortality with other non-adsorbent membrane versus adsorbent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of adipocytokines concentration</measure>
    <time_frame>one year</time_frame>
    <description>Evolution of four types of adipocytokines (ghrelin, leptin, adiponectin, resistin)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">106</enrollment>
  <condition>ESRD</condition>
  <arm_group>
    <arm_group_label>PEPA membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PEPA membrane is an adsorbant synthetic copolymer (Poly Ester Poly Arylate)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non adsorbent membrane</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Comparison with non adsorbent membrane used in routine</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PEPA</intervention_name>
    <arm_group_label>PEPA membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with Chronic Renal Insufficiency Stage 5, treated by fistula or permanent
             catheters,

          -  Medium albumin (on 3 recent assays) of less than 35 g / l (this assay being carried
             out by a non-electrophoretic technique),

          -  PINI score greater than or equal to 1,

          -  Beginning of the treatment of extra-renal purification by hemodialysis for at least 3
             months on a non-adsorbing synthetic membrane (of the Polysulfone, Polyethersulfone,
             PolyArylethersulfone type) of surface at least equal to that of the PEPA dialyser

        Exclusion Criteria:

          -  Patients allergic to PEPA,

          -  Patients with insufficient vascular access,

          -  Patients with digestive syndromes: Hepatopathy, gastrointestinal amyloidosis, chronic
             diarrhea, myeloma and dysglobulinaemia, neoplasia and hematopathy, a serious illness
             that is life-threatening in the short term,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BERNARD HORY, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Néphrologie, 4 ter rue de la Forêt, Avignon, FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BERNARD HORY, Doctor</last_name>
    <phone>+33 2 28072900</phone>
    <email>horybernard@ymail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christophe Robino, Doctor</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ch Annonay</name>
      <address>
        <city>Annonay</city>
        <zip>07103</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent BISSACCIA, Doctor</last_name>
    </contact>
    <contact_backup>
      <last_name>Carole DEPRELE, Doctor</last_name>
    </contact_backup>
    <investigator>
      <last_name>Eric LEGRAND, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Michel MARC, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Besancon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria YANNARAKI, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ch Chartres</name>
      <address>
        <city>Chartres</city>
        <zip>28018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine ALBERT, Doctor</last_name>
    </contact>
    <contact_backup>
      <last_name>Nabila GOUMRI, Doctor</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ch La Rochelle</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois POURREAU, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH MEAUX</name>
      <address>
        <city>Meaux</city>
        <zip>77104</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hala MOURAM, Doctor</last_name>
    </contact>
    <contact_backup>
      <last_name>Ibrahim FARAH, Doctor</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ch Metz-Thionville</name>
      <address>
        <city>Metz</city>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zead TUBAIL, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aura Paris Plaisance</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal SERIS, Doctor</last_name>
    </contact>
    <contact_backup>
      <last_name>Maeva CLERTE, Doctor</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CH Saint Brieuc</name>
      <address>
        <city>Saint-Brieuc</city>
        <zip>22027</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rehouni BOULAHROUZ, Doctor</last_name>
    </contact>
    <contact_backup>
      <last_name>Caroline FREGUIN, Doctor</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CH Saint Quentin</name>
      <address>
        <city>Saint-Quentin</city>
        <zip>02321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahen AL BADAWY, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ch Toulouse Larrey</name>
      <address>
        <city>Toulouse</city>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud DEL BELLO, Doctor</last_name>
    </contact>
    <contact_backup>
      <last_name>Ines FERRANDIZ, Doctor</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Chru Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maud FRANCOIS, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHPM Monaco</name>
      <address>
        <city>Monaco</city>
        <state>MC</state>
        <zip>98014</zip>
        <country>Monaco</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuela DAVIN, Doctor</last_name>
    </contact>
    <contact_backup>
      <last_name>Christophe Robino, Doctor</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
    <country>Monaco</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 26, 2019</study_first_submitted>
  <study_first_submitted_qc>December 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2019</study_first_posted>
  <last_update_submitted>December 3, 2019</last_update_submitted>
  <last_update_submitted_qc>December 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

